Tenax Therapeutics Financials - Benzinga

Tenax Therapeutics Inc

TENXNASDAQ

Trade with Public

Trade with Public

$1.86

-0.09-4.62%

At close: Sep 11, 5:00 PM EST

$1.87

0.00850.46%

After Hours: Sep 11, 7:59 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Tenax Therapeutics Financials

Tenax Therapeutics (TENX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Tenax Therapeutics Q2 EPS $(0.35) Beats $(0.37) Estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 29.63 percent decrease over losses of $(0.27) per share

Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

PRO
Tenax Therapeutics Q1 EPS $(0.35) Beats $(0.58) Estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.58) by 39.66 percent. This is a 25 percent decrease over losses of $(0.28) per share from

Benzinga Newsdesk

PRO
Tenax Therapeutics Q4 EPS $(0.38) Beats $(0.41) Estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 111.11 percent decrease over losses of $(0.18) per share

Benzinga Newsdesk

PRO
Tenax Therapeutics Q3 EPS $(0.40) Misses $(0.32) Estimate

Benzinga Newsdesk

PRO
Tenax Therapeutics Q2 EPS $(0.27) Misses $(0.24) Estimate

Benzinga Newsdesk